Document is current

Article History

Received: 19 April 2021

Accepted: 20 August 2021

First Online: 11 October 2021

Declarations

:

: This study is approved by the Institutional Review Board, Ohio University, IRB# 20-E-56; date of approval February 3, 2020. This study is exempt from informed consent requirement because the dataset used for analysis is publicly accessible. The authors have confirmed that all <b>methods were performed in accordance with the relevant guidelines and regulations.</b>

: Not applicable.

: JTG, B Chavan, LY, & ZTH, report no competing interests. In the past 5 years, B Clark has received research funding from NMD Pharma, Regeneron Pharmaceuticals, Astellas Pharma Global Development Inc., and RTI Health Solutions for contracted studies involving aging and muscle-related research. In the past 5 years, B Clark has received consulting fees from Regeneron Pharmaceuticals, Zev industries, and the Gerson Lehrman Group for consultation specific to age-related weakness and physical function-related research. B Clark is a co-founder with equity of Os-teoDx. ZH is an associate editor of this journal.